topic trial
Showing 1 - 25 of 2,892
Postoperative Pain Trial (Comparison of analgesic efficacy protocol)
Completed
- Postoperative Pain
- Comparison of analgesic efficacy protocol
- (no location specified)
Apr 25, 2023
COPD Exacerbation Acute Trial in Royal Oak (Trimethoprim Sulfamethoxazole, Placebo)
Recruiting
- COPD Exacerbation Acute
- Trimethoprim Sulfamethoxazole
- Placebo
-
Royal Oak, MichiganWilliam Beaumont Hospital
Sep 28, 2022
Lichen Sclerosus Trial in Winterthur (Treatment with Monalisa Glide Laser, Treatment with Clobetasol)
Recruiting
- Lichen Sclerosus
- Treatment with Monalisa Glide Laser
- Treatment with Clobetasol
-
Winterthur, Zürich, SwitzerlandKantonsspital Winterthur
Nov 14, 2023
COPD, Chronic Bronchitis Trial in Birmingham (Ivacaftor 150 MG, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Chronic Bronchitis
- Ivacaftor 150 MG
- Placebo
-
Birmingham, AlabamaUAB Lung Health Center
Mar 24, 2022
Eczema Trial in Rimouski (Omega-3 monoglyceride based topical treatment)
Not yet recruiting
- Eczema
- Omega-3 monoglyceride based topical treatment
-
Rimouski, Quebec, CanadaSCF Pharma
Dec 1, 2023
Chronic Disease, Patient Education as Topic, Patient Adherence Trial in Lille (Questionnaire)
Completed
- Chronic Disease
- +4 more
- Questionnaire
-
Lille, FranceHôpital Claude Huriez, CHU
Oct 14, 2022
Pain, Abortion, Spontaneous Trial in Panama (Lidocain topical + paracervical blockade, Lidocaine topical)
Completed
- Pain
- Abortion, Spontaneous
- Lidocain topical + paracervical blockade
- Lidocaine topical
-
Panama, PanamaSaint Thomas H
Oct 4, 2021
Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,
Recruiting
- Hepatitis C
- +2 more
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
- Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
-
Randwick, New South Wales, Australia
- +6 more
Mar 28, 2022
Smoking Cessation Trial in Leiden (Lapse prevention dialog: Boost motivation and self-efficacy, Lapse prevention dialog:
Recruiting
- Smoking Cessation
- Lapse prevention dialog: Boost motivation and self-efficacy
- +3 more
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center (LUMC)
Dec 8, 2022
Bone Diseases, Communication Trial (Health Maintenance Topic, Actionable Sidebar Item, Best Practice Alert)
Withdrawn
- Bone Diseases
- Communication
- Health Maintenance Topic
- +2 more
- (no location specified)
Mar 16, 2022
Substance Use Disorders, PTSD Trial in West Haven (Written Exposure Therapy, Neutral Topic Writing)
Recruiting
- Substance Use Disorders
- Posttraumatic Stress Disorder
- Written Exposure Therapy
- Neutral Topic Writing
-
West Haven, ConnecticutVA Connecticut Healthcare System West Haven Campus, West Haven,
Sep 7, 2022
Elderly Urinary Incontinence Caregiver Burden
Completed
- Caregiver Burden
- Urinary Incontinence
- no intervention
-
Ankara, TurkeyAnkara Medipol University
Mar 3, 2022
Patient Enablement in Osteoarthritis -Longitudinal Study on
Completed
- Patient Education as Topic
- Osteoarthritis
- Patient education for osteoarthritis
-
Malmo, SwedenPrimary Health Care
Feb 25, 2022
Cataract, Anxiety Trial (MusicCare® device, Headphones with noise reduction)
Not yet recruiting
- Cataract
- Anxiety
- MusicCare® device
- Headphones with noise reduction
- (no location specified)
Mar 24, 2021
Glaucoma Trial in Montréal (Topic insulin (4 units), Topic insulin (20 units))
Suspended
- Glaucoma
- Topic insulin (4 units)
- Topic insulin (20 units)
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Aug 16, 2021
VARICOSE VEINS Trial in Osasco (TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G)
Withdrawn
- VARICOSE VEINS
- TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G
-
Osasco, São Paulo, BrazilMedcin Instituto Da Pele
Feb 23, 2021
Vulvar Lichen Sclerosus Trial in Bern (Clobetasol propionate 0.05%, Progesterone 8%)
Terminated
- Vulvar Lichen Sclerosus
- Clobetasol propionate 0.05%
- Progesterone 8%
-
Bern, SwitzerlandDep. of Obstetrics and Gynecology, Bern University Hospital
Mar 21, 2022
Atopic Dermatitis Trial in Pierre-Bénite (Lactibiane Topic AD, Placebo)
Completed
- Atopic Dermatitis
- Lactibiane Topic AD
- Placebo
-
Pierre-Bénite, FranceUnité de Recherche Clinique en Immunologie - Lyon Sud
Jan 28, 2021
Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children Trial in Danville (Best Practice Alert,
Completed
- Hypercholesterolemia
- +3 more
- Best Practice Alert
- Health Maintenance Topic
-
Danville, PennsylvaniaGeisinger Health System
Jan 7, 2022
Alzheimer, Alzheimer, Late Onset, Memory Loss Trial in New York (Web-based education)
Recruiting
- Alzheimer Disease
- +3 more
- Web-based education
-
New York, New YorkWeill Medical College of Cornell University
Jan 28, 2022
Educating Brain Tumor Patients Using Patient-specific
Recruiting
- Brain Tumor
- +7 more
- Three-dimensional printed model
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jul 10, 2021
Endometrial Tumors Trial in Spain (Pembrolizumab)
Completed
- Endometrial Neoplasms
-
Hospitalet de Llobregat, Barcelona, Spain
- +6 more
Oct 4, 2021
USEFULNESS of Topic Ivermectin and Carrageenan to Prevent
Completed
- Covid19
- Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops)
-
Buenos Aires, ArgentinaHospital Eurnekian
Oct 15, 2020